10MD receives funding from Swelife

10MD has received funding from the Swedish Innovation Programme for Life Science, SWElife. The funding will primarily be used to support 10MD market access activities.

Ten Medical Design AB (10MD) is a medical technology company committed to providing innovative products to healthcare professionals. In October 2015, 10MD was granted its first patent approval for the attenuating material TeXray. TeXray is capable of reaching industry standards of X-ray attenuation within the range of 30-150kV, while simultaneously enabling the design of ergonomic and hygienic personal protection equipment. TeXray is expected to reach the market in 2018.

- "I am pleased to announce that Swelife has decided to financially support 10MD in this exciting stage of taking our first product to market," says Mr Fredrik Gellerstedt, CEO of 10MD.

Leave a comment

Please note, comments must be approved before they are published